References
- Stewart LC, Langtry JA. Clopidogrel: Mechanisms of action and review of the evidence relating to use during skin surgery procedures. Clin Exp Dermatol 2010;35:341–345.
- Makkar K, Wilensky RL, Julien MB, Herrmann HC, Spinler SA. Rash with both clopidogrel and ticlopidine in two patients following percutaneous coronary intervention with drug-eluting stents. Ann Pharmacother 2006;40:1204–1207.
- Fernandez DG, Fuentes-Vallejo MS, Rueda-Ygueravides MD, Foncubierta-Fernandez A, Leon-Jimenez A. Immediate hypersensitivity and delayed hypersensitivity to clopidogrel. Allergol Immunopathol 2007;35:213–215.
- Guijarro Guijarro B, Lopez Sanchez AF. Lichenoid reaction caused by clopidogrel, a new anti-platellet drug. Med Oral 2003;8:33–37.
- Ghosh SK, Bandyopadhyay D. Clopidogrel-induced fixed drug eruption. J European Acad Dermatol Venereol 2009;23:1202–1203.
- Ghosh S, Bandyopadhyay D. Haemorrhagic herpes zoster associated with clopidogrel treatment. Clin Exp Dermatol 2008;34:402–425.
- Nakamizo S, Kobayashi S, Usui T, Miyachi Y, Kabashima K. Clopidogrel-induced acute generalized exanthematous pustulosis with elevated Th17 cytokine levels as determined by a drug lymphocyte stimulation test. Br J Dermatol 2010;162:1402–1403.
- Soter NA, Diaz-Perez JL. (2008). Cutaneous necrotizing venulitis. In: Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ. Fitzpatrick’s Dermatology in General Medicine, ed. 7th edition. New-York: McGraw–Hill, 1599–1606.
- Kawakami T. New algorithm (KAWAKAMI algorithm) to diagnose primary cutaneous vasculitis. J Dermatol 2010;37:113–124.
- Calabrese LH, Michel BA, Bloch DA, Arend WP, Edworthy SM, Fauci AS, Fries JF, Hunder GG, Leavitt RY, Lie JT. The American Collage of Rheumatology 1990 criteria for the classification of hypersensitivity vasculitis. Arthritis Rheum 1990;33:1108–1113.
- Bahrami S, Malone JC, Webb KG, Callen JP. Tissue eosinophilia as an indicator of drug-induced cutaneous small-vessel vasculitis. Arch Dermatol 2006;142:155–161.